Alzheimer Disease Clinical Trials in London, Ontario
6 recruitingLondon, Ontario, Canada
Showing 1–6 of 6 trials
Recruiting
Phase 3
A Study to Evaluate the Long-term Efficacy and Safety of KarXT + KarX-EC for Agitation in Alzheimer's Disease (ADAGIO-3)
Alzheimer DiseaseAgitation
Bristol-Myers Squibb600 enrolled241 locationsNCT06937229
Recruiting
Phase 3
A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease (ADAGIO-1)
Alzheimer Disease
Bristol-Myers Squibb352 enrolled157 locationsNCT07011732
Recruiting
Phase 2
Cannabidiol Medication Intervention Trial
Alzheimer Disease
Sunnybrook Health Sciences Centre40 enrolled5 locationsNCT06014424
Recruiting
Phase 3
Nabilone for Agitation Blinded Intervention Trial
Alzheimer DiseaseAgitation
Sunnybrook Health Sciences Centre112 enrolled6 locationsNCT04516057
Recruiting
Comprehensive Assessment of Neurodegeneration and Dementia
DementiaMild Cognitive Impairment (MCI)Subjective Cognitive Impairment+7 more
McGill University1,573 enrolled19 locationsNCT03402919
Recruiting
Gait as Predictor of Dementia and Falls. The Gait and Brain Cohort Study
DementiaAlzheimer DiseaseMild Cognitive Impairment+3 more
Manuel Montero Odasso600 enrolled1 locationNCT03020381